SEARCH

SEARCH BY CITATION

References

  • 1
    Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 2003; 10: 7277.
  • 2
    Miyawaki I, Moriyasu M, Funabashi H, Yasuba M, Matsuoka N. Mechanism of clobazam-induced thyroidal oncogenesis in male rats. Toxicol Lett 2003; 145: 291301.
  • 3
    Karmali RA, Volkman A, Muse P, Louis TM. The influence of diazepam administration in rats bearing the R3230AC mammary carcinoma. Prostaglandins Med 1979; 3: 193198.
  • 4
    Iida M, Anna CH, Hartis J, Bruno M, Wetmore B, Dubin JR, Sieber S, Bennett L, Cunningham ML, Paules RS, Tomer KB, Houle CD, Merrick AB, Sills RC, Devereux TR. Changes in global gene and protein expression during early mouse liver carcinogenesis induced by non-genotoxic model carcinogens oxazepam and Wyeth-14,643. Carcinogenesis 2003; 24: 757770.
  • 5
    International Agency for Research on Cancer (IARC). IARC monograph volume 66. 1996. Available at http://monographs.iarc.fr/ENG/Monographs/vol66/mono66.pdf (last accessed 26 October 2012).
  • 6
    Kripke DF. Possibility that certain hypnotics might cause cancer in skin. J Sleep Res 2008; 17: 245250.
  • 7
    Pogoda JM, Katz J, McKean-Cowdin R, Nichols PW, Ross RK, Preston-Martin S. Prescription drug use and risk of acute myeloid leukemia by French-American-British subtype: results from a Los Angeles County case-control study. Int J Cancer 2005; 114: 634638.
  • 8
    Halapy E, Kreiger N, Cotterchio M, Sloan M. Benzodiazepines and risk for breast cancer. Ann Epidemiol 2006; 16: 632636.
  • 9
    Kaufman DW, Werler MM, Palmer JR, Rosenberg L, Stolley PD, Warshauer ME, Clarke EA, Miller DR, Shapiro S. Diazepam use in relation to breast cancer: results from two case-control studies. Am J Epidemiol 1990; 131: 483490.
  • 10
    Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Strom BL, Harlap S, Shapiro S. Relation of benzodiazepine use to the risk of selected cancers: breast, large bowel, malignant melanoma, lung, endometrium, ovary, non-Hodgkin's lymphoma, testis, Hodgkin's disease, thyroid, and liver. Am J Epidemiol 1995; 141: 11531160.
  • 11
    Coogan PF, Rosenberg L, Palmer JR, Strom BL, Stolley PD, Zauber AG, Shapiro S. Risk of ovarian cancer according to use of antidepressants, phenothiazines, and benzodiazepines (United States). Cancer Causes Control 2000; 11: 839845.
  • 12
    Dublin S, Rossing MA, Heckbert SR, Goff BA, Weiss NS. Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications. Cancer Causes Control 2002; 13: 3545.
  • 13
    Kripke DF, Langer RD, Kline LE. Hypnotics' association with mortality or cancer: a matched cohort study. BMJ Open 2012; 2: e000850.
  • 14
    Thygesen LC, Ersboll AK. Danish population-based registers for public health and health-related welfare research: introduction to the supplement. Scand J Public Health 2011; 39: 810.
  • 15
    Frank L. Epidemiology. When an entire country is a cohort. Science 2000; 287: 23982399.
  • 16
    Ray WA. Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 2003; 158: 915920.
  • 17
    Storm HH, Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry – history, content, quality and use. Dan Med Bull 1997; 44: 535539.
  • 18
    Gjerstorff ML. The Danish Cancer Registry. Scand J Public Health 2011; 39: 4245.
  • 19
    Jensen AR, Overgaard J, Storm HH. Validity of breast cancer in the Danish Cancer Registry. A study based on clinical records from one county in Denmark. Eur J Cancer Prev 2002; 11: 359364.
  • 20
    Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health 2011; 39: 3033.
  • 21
    Kildemoes HW, Sorensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health 2011; 39: 3841.
  • 22
    WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC Classification and DDD Assignment 2011. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 2010.
  • 23
    Pedersen CB. The Danish Civil Registration System. Scand J Public Health 2011; 39: 2225.
  • 24
    Baadsgaard M, Quitzau J. Danish registers on personal income and transfer payments. Scand J Public Health 2011; 39: 103105.
  • 25
    Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health 2011; 39: 9194.
  • 26
    Rothman KJ, Greenland S, Lash TL. Modern Epidemiology, 3rd edn. Philadelphia, PA: Wolters Kluwer Health, Lippincott Williams & Wilkins, 2008.
  • 27
    Jørgensen T, Herrstedt J, Friis S, Hallas J. Danish cancer patients during 1996 to 2006. J Geriatr Oncol 2012; 3: 3340.
  • 28
    Csizmadl I, Collet J-P, Boivin J. Bias and confounding in pharmacoepidemiology. In: Pharmacoepidemiology, 4th edn, ed. Strom BL . West Sussex: Wiley and Sons, 2007; 791810.
  • 29
    Hallas J, Gaist D, Bjerrum L. The waiting time distribution as a graphical approach to epidemiologic measures of drug utilization. Epidemiology 1997; 8: 666670.
  • 30
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373383.
  • 31
    Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sorensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol 2011; 11: 83.
  • 32
    Secretan B, Straif K, Baan R, Grosse Y, El GF, Bouvard V, Benbrahim-Tallaa L, Guha N, Freeman C, Galichet L, Cogliano V. A review of human carcinogens – Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10: 10331034.
  • 33
    Baan R, Straif K, Grosse Y, Secretan B, El GF, Bouvard V, Altieri A, Cogliano V. Carcinogenicity of alcoholic beverages. Lancet Oncol 2007; 8: 292293.
  • 34
    World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective. Washington DC: AICR, 2007.
  • 35
    Andersen M, Pottegard A, Friis S, Hallas J. Hypnotics' association with mortality or cancer: bias related to the study design and analysis. Letter to the editor. BMJ Open 2012; 2: e000850.
  • 36
    Taubes G. Epidemiology faces its limits. Science 1995; 269: 164169.
  • 37
    Austin H, Hill HA, Flanders WD, Greenberg RS. Limitations in the application of case-control methodology. Epidemiol Rev 1994; 16: 6576.
  • 38
    Manthey L, Lohbeck M, Giltay EJ, van Veena T, Zitman FG, Penninx BW. Correlates of benzodiazepine dependence in the Netherlands Study of Depression and Anxiety. Addiction 2012. doi: 10.1111/j.1360-0443.2012.03975.x.
  • 39
    Cheron-Launay M, Le Faou AL, Sevilla-Dedieu C, Gilbert F, Kovess-Masfety V. Smoking and the consumption of antidepressants, anxiolytics and hypnotic drugs: results of a large, French epidemiological study in 2005. Addict Behav 2011; 36: 743748.
  • 40
    Naja WJ, Pelissolo A, Haddad RS, Baddoura R, Baddoura C. A general population survey on patterns of benzodiazepine use and dependence in Lebanon. Acta Psychiatr Scand 2000; 102: 429431.
  • 41
    Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169.